The increasing number of hereditary angioedema cases and the hereditary nature giving the
disease an ability to pass the defective gene to the future generations is expected to propel
market growth. According to the survey by International Hereditary Angioedema Organization
(HAEi), 2015, the global prevalence of hereditary angioedema is estimated to be around 1 in
10,000 to 50,000 people, meaning that around a quarter million people suffer globally from this
rare and life threatening deficiency condition. Also, according to National Association for Rare
Disorders, 2016, the risk of passing the abnormal gene from affected parent to offspring is 50%
for each pregnancy regardless of the sex of the resulting child. North America dominates the
hereditary angioedema market, owing to the higher number of drugs approved in the regions,
presence of major manufacturers and the presence of various organizations serving HAE
patients. In 2017, the U.S. Food and Drug Administration (FDA) approved Haegarda (C1-esterase
inhibitor) manufactured by CSL Behring for routine prophylaxis to prevent HAE attacks in
adolescent and adult patients. However, the rare occurrence of the disease make it difficult for
efficient diagnosis and either opt for alternative therapies to control the disease, thus accounting
to be the major factors restraining the market growth.
Report includes chapters which deeply display the following deliverable about industry :
• Hereditary Angioedema Market Research Objective and Assumption
• Hereditary Angioedema Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Hereditary Angioedema Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Hereditary Angioedema Market, By Regions
• Hereditary Angioedema Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Hereditary Angioedema Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Hereditary Angioedema Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Hereditary Angioedema Market Forecast including Production, Consumption, Import and